Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment
暂无分享,去创建一个
J. Hardy | K. Morgan | C. Holmes | R. Guerreiro | J. Bras | P. Francis | S. Chaudhury | K. Brookes | T. Patel | Abigail Fallows | T. Guetta-Baranés | J. Turton | Rebecca Croucher | A. Thomas | T. Guetta‐Baranés | Tulsi A. Patel | Tamar Guetta‐Baranés
[1] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[2] A. Mitchell,et al. Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.
[3] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[4] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[5] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[6] R. Buckner,et al. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. , 2012, Cerebral cortex.
[7] O. Combarros,et al. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease , 2013, Journal of Neural Transmission.
[8] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[9] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[10] C. Reitz,et al. Genome-wide Association Studies in Alzheimer’s Disease: A Review , 2013, Current Neurology and Neuroscience Reports.
[11] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[12] Benjamin F. J. Verhaaren,et al. Alzheimer's Disease Genes and Cognition in the Nondemented General Population , 2013, Biological Psychiatry.
[13] C. Holmes,et al. Systemic inflammatory responses to stress and its impact on cognition in people with mild cognitive impairment , 2013, Alzheimer's & Dementia.
[14] P. Deyn,et al. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42 , 2015, Alzheimer's & Dementia.
[15] A. Hofman,et al. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia , 2015, Alzheimer's & Dementia.
[16] M. Gill,et al. Common polygenic variation enhances risk prediction for Alzheimer's disease. , 2015, Brain : a journal of neurology.
[17] B. Miller,et al. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease , 2015, BMC Neurology.
[18] Jens Keilwagen,et al. PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R , 2015, Bioinform..
[19] Takaya Saito,et al. The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets , 2015, PloS one.
[20] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[21] V. Pankratz,et al. Late-onset Alzheimer’s risk variants in memory decline, incident mild cognitive impairment, and Alzheimer’s disease , 2015, Neurobiology of Aging.
[22] T. Lehtimäki,et al. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. , 2014, Journal of Alzheimer's disease : JAD.
[23] Jianfeng Xu,et al. Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population , 2015, Oncotarget.
[24] Jack Euesden,et al. PRSice: Polygenic Risk Score software , 2014, Bioinform..
[25] I. Kawachi,et al. Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up , 2016, Alzheimer disease and associated disorders.
[26] A. Ruiz,et al. Genome research in pre-dementia stages of Alzheimer's disease , 2016, Expert Reviews in Molecular Medicine.
[27] Theresa M. Harrison,et al. An Alzheimer’s Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults , 2016, eNeuro.
[28] R. Buckner,et al. Polygenic risk of Alzheimer disease is associated with early- and late-life processes , 2016, Neurology.
[29] Amelia A. Assareh,et al. The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume , 2016, Neurobiology of Aging.
[30] A. Hofman,et al. Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[31] Sonja W. Scholz,et al. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases , 2017, Neurobiology of Aging.
[32] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[33] D. Schaid,et al. Polygenic risk scores in familial Alzheimer disease , 2017, Neurology.
[34] Lilah M. Besser,et al. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.
[35] R. Sims,et al. The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[36] J. Hardy,et al. Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease , 2017, Neurobiology of Aging.
[37] Yunxia Jiang,et al. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis , 2017, Clinical interventions in aging.
[38] A. Myers,et al. Polygenic risk score analysis of pathologically confirmed Alzheimer disease , 2017, Annals of neurology.
[39] Lilah M. Besser,et al. Polygenic hazard scores in preclinical Alzheimer’s disease , 2017, bioRxiv.
[40] K. Morgan,et al. Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort. , 2018, Journal of Alzheimer's disease : JAD.
[41] D. Hernandez,et al. Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease , 2018, Neurobiology of Aging.
[42] P. Francis,et al. Brains for Dementia Research: Evolution in a Longitudinal Brain Donation Cohort to Maximize Current and Future Value , 2018, Journal of Alzheimer's disease : JAD.
[43] E. Topol,et al. The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.
[44] H. Hakonarson,et al. Polygenic Risk Score for Alzheimer's Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life. , 2018, The American journal of psychiatry.
[45] O. Andreassen,et al. Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s , 2019, Molecular Psychiatry.